• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES AORTIC TAG THORACIC ENDOPROSTHESIS (CTAG); SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES AORTIC TAG THORACIC ENDOPROSTHESIS (CTAG); SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number TGU404015
Medical Device Problem Code Compatibility Problem (2960)
Health Effect - Clinical Code Aneurysm (1708)
Date of Event 12/11/2018
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
As it is unknown what device the endoleak was attributed to, additional devices implanted: tgu404010/(b)(4) and tgu404010/(b)(4) have been listed.According to the conformable gore® tag® thoracic endoprosthesis instructions for use, complications associated with the use of the gore® tag® thoracic endoprosthesis that may occur and/or require intervention include, but are not limited to: endoleak.The review of the manufacturing paperwork verified that these lots met all pre-release specifications.
 
Event or Problem Description
On (b)(6) 2014, the patient was treated for a thoracic aortic aneurysm using endologix stent graft and conformable gore® tag® thoracic endoprostheses.On an unknown date, imaging identified a type iii endoleak component disconnect between the endologix device and a ctag device (lot number unknown).It was reported the cause of type iii endoleak is unknown.No aneurysm enlargement was reported.On (b)(6) 2018, a reintervention was performed bridging the two devices.The endoleak was reportedly resolved and the patient tolerated the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AORTIC TAG THORACIC ENDOPROSTHESIS (CTAG)
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key8238055
Report Number2017233-2019-00019
Device Sequence Number1607594
Product Code MIH
UDI-Device Identifier00733132618163
UDI-Public00733132618163
Combination Product (Y/N)N
Initial Reporter StateNJ
Initial Reporter CountryUS
PMA/510(K) Number
P040043
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2014
Reporter Type Manufacturer
Report Source company representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 12/11/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date06/30/2015
Device Catalogue NumberTGU404015
Device Lot Number10513063
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date01/10/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient Age77 YR
-
-